好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2025 Annual Meeting | C15 - Pediatric Vascular Neurology

Saturday 04/05/25
12:00 PM - 02:00 PM PDT Add To Calendar
San Diego Convention Center | 28D
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Catherine M. Amlie-Lefond, MD, FAAN
Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology
Participants should gain an understanding of the early complications that can occur in children following acute stroke; describe current use of genetic testing to inform care of vascular disorders in childhood; and recognize the importance sickle cell disease in neurovascular health.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Advanced
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
12:00 PM - 12:05 PM PDT Introduction Welcome to Pediatric Vascular Neurology
Catherine M. Amlie-Lefond, MD, FAAN
12:05 PM - 12:40 PM PDT Speaker Early Complications Following Pediatric Stroke
Giulia Benedetti, MD
12:40 PM - 01:15 PM PDT Speaker What is the Role of Genetic Testing in Pediatric Vascular Neurology?
Catherine M. Amlie-Lefond, MD, FAAN
01:15 PM - 01:50 PM PDT Speaker Sickle Cell Disease and the Brain
Melanie Fields, MD, MSc
01:50 PM - 02:00 PM PDT Speaker Questions and Answers
Catherine M. Amlie-Lefond, MD, FAAN, Giulia Benedetti, MD, Melanie Fields, MD, MSc
Faculty Disclosures
Catherine M. Amlie-Lefond, MD, FAAN Dr. Amlie-Lefond has nothing to disclose.
Giulia Benedetti, MD The institution of Dr. Benedetti has received research support from Pediatric Epilepsy Research Foundation. The institution of Dr. Benedetti has received research support from NIH.
Melanie Fields, MD, MSc Melanie Fields, MD, MSc has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Melanie Fields, MD, MSc has stock in ProClara Biosciences. The institution of Melanie Fields, MD, MSc has received research support from NIH NHLBI. Melanie Fields, MD, MSc has received personal compensation in the range of $500-$4,999 for serving as a Advisor with Guidepoint. Melanie Fields, MD, MSc has received personal compensation in the range of $500-$4,999 for serving as a Advisor with Dedham Group.